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ORIGINAL ARTICLE
AHSG rs4918 Polymorphism poses a weak predisposition to insulin resistance
during pregnancy
Aisha Tariq,1 Aleezay Asghar,2 Faiza Alam,3 Syeda Sadia Fatima4

Abstract
Objective: To identify the association between Fetuin-A levels and genetic polymorphism with gestational diabetes
mellitus among pregnant women visiting a tertiary care centre.
Methods: This cross-sectional case-control study was conducted at Aga Khan University Hospital, Karachi, from
December 2015 to September 2016, and comprised pregnant women in their second trimester. Those with
gestational diabetes mellitus were considered the cases while the rest acted as controls. The enzyme-linked
immunosorbent assay was used to quantify Fetuin-A levels while genotyping for alpha-2-Heremans-Schmidglycoprotein rs4918 was performed using restriction fragment length polymorphism technique. Blood samples
were collected and serum and deoxyribonucleic acid were extracted and stored at -80°C. SPSS 21 was used to
analyse the findings.
Results: Of the 88 subjects, there were 44(50%) in each group. Serum Fetuin-A concentration was higher in cases
compared to the controls (p<0.01). The genotype data for the cases was 0.668 and for the controls 0.840 (p>0.05).
However, the G allele showed a weak risk or predisposition towards gestational diabetes mellitus (p=0.038).
Conclusion: Increased Fetuin-A levels were found to be related to the occurrence of gestational diabetes mellitus,
indicating that Fetuin-A possibly contributes towards insulin resistance.
Keywords: AHSG polymorphism, Fetuin-A, Gestational diabetes mellitus. (JPMA 68: 698; 2018)

Introduction
Fetuin-A was first identified in foetal bovine serum and is
known as either alpha-2- -Heremans-Schmid glycoprotein
(AHSG). It works as a key component in numerous
physiological and pathological processes.1 It is known to
act as a potent inhibitor of calcification, controls protease
activity, keratinocytes migration and initiates breast
tumour cell proliferative signalling.2 Studies suggest that
low serum levels lead to multiple complications including
cerebrovascular events.1 Despite a positive correlation
between serum Fetuin-A levels and calcium deposition;
further research has failed to establish a correlation of
Fetuin-A in subjects with a low cerebral vascular risk.3
Serum Fetuin-A levels also influence the body's defence
mechanisms such as inflammatory regulation for
macrophage deactivation. Moreover, Fetuin-A can
potentially serve as a diagnostic biomarker for metabolic
syndromes, liver diseases and cardiovascular diseases.4
This 57 kD protein also plays a significant role during normal
pregnancy. Higher levels are found in pregnancy,5 however
in neonates with intrauterine growth restriction (IUGR),
defective expression and glycosylation of Fetuin-A was
1,2Aga
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observed, which may be responsible for poor foetal growth.6
This theory is further supported by the finding that Fetuin-A
is a key constituent of the non-collagenous bone matrix,
particularly in the foetal age.6 Correlation of Fetuin-A levels
with successful pregnancies in women undergoing assisted
pregnancy has also been deduced,5 indicating Fetuin-A's
possible role in normal gametogenesis and fertilisation.
Fetuin-A is encoded by the AHSG gene located at the
chromosome 3q27, composed of seven exons and
spanning 8.2 kb of deoxyribonucleic acid (DNA).7 The gene
has multiple variants but the specific allele of interest for
this study is rs4918. This allele is found at position 256 of
Exon 7. The most common polymorphism recorded for
this area is the C (Thr)gG (Ser) mutation. The allele is said
to be associated with maintaining good body mass index
(BMI), body fat and controlling insulin sensitivity.
Furthermore, it shows a protective effect against dietinduced obesity,8 diabetes and metabolic syndrome,7 and
is therefore called the 'lean gene'. Healthy individuals with
the G allele have been found to have lower inflammatory
cytokines such as the tumour necrosis factor alpha (TNFa)
and adiponectin levels while higher levels of leptin are
found.9 Even in patients with a history of myocardial
infarction (MI), the presence of rs4918 G allele renders
better anthropometric parameters such as BMI and waist
circumference.9 On the contrary, the allele also
predisposes carriers like those with a single G allele to
J Pak Med Assoc
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certain conditions including insulin resistance (IR). FetuinA binds to receptors for insulin in liver and muscles, which
function through tyrosine kinase,10,11 thus contributes to
(IR) (Figure). Moreover, it has been linked to causing
accumulation of fat in liver cells,12 which is a predisposing
factor for diabetes.
Gestational diabetes mellitus (GDM), described as the
diabetes that occurs only during the state of pregnancy, is
an illness of increasing prevalence in Pakistan.13,14 It has
been found to be associated with stillbirth and abnormal
birth weight, which places new born babies with a higher
birth weight at risk of cardiovascular disease.15 Research
has demonstrated that increased Fetuin-A is related to
increased GDM risk.10,16,17 One such study included
anthropometric measurements of newborn to relate
complications of GDM with increased Fetuin-A and TNFa,
among other factors, but their effect as potential
confounders was not ruled out.16 The current study was
planned to assess the association of Fetuin-A levels with
GDM, and to see whether AHSG rs4918 G allele acts as a
risk allele for GDM.

Subjects and Method
This cross-sectional case-control study was conducted at
Aga Khan University Hospital, Karachi, from December
2015 to September 2016, and comprised of pregnant
women in their second trimester. Those with gestational
diabetes mellitus were considered the cases while the rest
acted were labeled as controls. After getting approval
from the institutional ethics review committee, the
subjects were randomly enrolled from among those who
gave informed written consent.
The subjects were given 75g oral glucose (OGTT) solution
at 28th week of gestation and were categorised into two
equal groups of normoglycemic pregnancies and
patients with GDM in accordance with the criteria of the
International Association of the Diabetes and Pregnancy
Study Groups (IADPSG).18 Any individual with more than
92mg/dl fasting blood glucose and/or more than
153mg/dl blood glucose post-prandial was identified as a
diabetic. Females expecting more than one child, with a
past history of chronic illnesses including pre-gestational
diabetes, polycystic ovary syndrome (PCOS),
hypertension, hepatic and/or renal impairment, on
hormonal supplements and/or anti-inflammatory drugs
were excluded from this study.
The sample size was calculated by OpenEpi software.
Assuming a confidence level of 95%, power of 80%, least
extreme odds ratio (OR) of 2 and a GDM prevalence of 17%
as per our recent report,19 the minimum sample size of
n=89 was required to have a meaningful result of this study
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(n = [DEFF*Np(1-p)]/ [(d2/Z21-a/2*(N-1)+p*(1-p)]) [Where: N=
Population size; p = Hypothesized % frequency of outcome
factor in the population; d= Confidence limits; DEFF=
Design effect (for cluster surveys-); n=Sample Size(n)].
The anthropometric, demographic and personal data of
each patient was recorded. After that, 10 ml blood samples
were taken from each individual and extracted serum was
stored at -80°C. DNA was extracted from whole blood
samples stored in ethylenediaminetetraacetic acid (EDTA)
tubes using Qaigen Genomic DNA extraction kits (Cat.
Number 51185, Valencia, USA). Sandwich enzyme-linked
immunosorbent assay (ELISA) kits were used to measure
serum Fetuin-A levels (Kit Cat# 95469 Glory science). Primers
used for the polymerase chain reaction (PCR) for AHSG
rs4918 were designed using the primer 3 software (Forward
5'-GTA AGG CAA CAC TCA GTG A-3'; Reverse 5'-TCA TCT CTG
CCA TGT CTA G-3'). PCR was performed using the Ruby Taq
PCR Master mix 2X (cat# 71191, Affymetrix, USA) as per the
manufacturer's instructions. The amplified product of 1,080
bp was digested with restriction endonuclease SacI
(Promega, USA) for 3 hours at 37°C to yield digested
products (725 and 355 bp). The digested fragments were
electrophoresed in 2% agarose gel. Genotypes were scored
by an independent person, who was blinded about the case
control status of the study subjects and each run had five
negative controls. Statistical analyses were conducted using
SPSS 21. Descriptive analysis of continuous variables was
expressed as mean ± standard deviation. Student t-test was
applied to compare groups. Hardy-Weinberg equilibrium
(HWE) was calculated for single nucleotide polymorphisms
(SNP) data. SNP data was analysed for genotype and allele
frequency determination by applying chi-squared statistics.
Genotypes were allotted code of 0/1/2 rendering the
number of minor alleles under a dominant model of
inheritance.

Results
A total of 88 pregnant women were divided into two
Table-1: General Characteristics of the study subjects.
Variable

Age (year)
Weight at booking (kg)
BMI (kg/m2)
OGTT-0 hour (mg/dl)
OGTT-2 hour (mg/dl)
Fetuin-A (ng/mL)

Gestational Diabetic
Females
(n=44)
Mean ± SD

Normo-glycemic
Pregnant Females
(n=44)
Mean ± SD

P value

27.27 ± 5.18
64.90 ± 11.98
25.80 ± 5.63
103.93 ± 11.70
176.20 ± 5.53
1856.53 ± 250.52

25.44 ± 4.64
59.26 ± 11.61
23.80 ± 4.65
80.28 ± 8.33
119.53 ± 15.90
1286 ± 95.44

0.053
0.032
0.069
<0.001
<0.001
0.01

BMI: Body mass index.
OGTT: Oral glucose tolerance test.
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Table-2: Genotype and Allele Frequency Distribution of the study subjects.
Genotype

Gestational Diabetic Females (n=44)

Normo-glycemic Pregnant Females (n=44)

OR (95% C.I)

P value

CC
CG
GG

18 (40.90)
21 (47.72)
8 (18.18)

25 (56.81)
16 (36.36)
3 (6.81)

Reference
1.823 (0.749-4.434)
2.120 (0.917-4.899)

p= 0.076

C
G

OR (95% C.I)
57 (60.64%)
37 (39.36%)

P value
66 (75%)
22 (25%)

1.947 (1.031-3.677)

0.0385

Allele Frequency

Figure: Schematic diagram showing insulin and it's inactivated receptor (A), insulin binding to its receptor, which works through tyrosine kinase to activate it (B) and Fetuin-A binding
to insulin's receptor, which blocks binding of insulin to its receptors (C), contributing to insulin resistance.

equal groups of 44(50%) cases and controls. There was no
difference between the groups in terms of age and BMI
(p>0.05). Serum Fetuin-A concentration was higher in
cases than controls (p<0.01) (Table-1). Genotype
distribution showed no significant difference between
the groups (p>0.05). However, the G allele showed a weak
risk or predisposition towards GDM (p=0.0385) (Table-2).

Discussion
Our study showed that GDM was correlated with higher
Fetuin-A levels (p= 0.01) in line with literature where
several studies have tried to understand the relation of
Fetuin-A with IR in GDM. Three such studies found high
levels of Fetuin-A in participants with GDM.16,17,20 whereas
one recent study introduced Fetuin-A and B as potential
risks for developing GDM.21 However, one study found
that levels of Fetuin-A did not relate with the
development of GDM.10 The different results could be
accounted for by the very limited sample size of 20

participants. Yet, we report a positive relation between
GDM and higher circulatory Fetuin-A levels. Furthermore,
we did not find any significant difference in BMI between
the case and control groups, perhaps due to the wellcontrolled diet plan for these patients prevented the
body weight fluctuation. The study results suggest that
increased Fetuin-A levels have a strong relation with
GDM. This finding strengthens the fact that Fetuin-A may
act as an important mediator for development of IR in
pregnancy. A possible mechanism of how Fetuin-A acts as
an inducer of IR could be by binding to tyrosine kinase
receptors and subsequently impeding downstream
signalling pathways.22
The AHSG gene polymorphism rs4918 has two variants; C
and G allele.23 It has been demonstrated that the C allele
correlates with a higher degree of allele expression, as
reflected by higher serum Fetuin-A levels in homozygotes
with rs4918 C allele.23 When we assessed the allele
J Pak Med Assoc
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frequencies the G allele was found to be more common in
GDM females compared to normoglycaemic pregnant
females. This finding implies that the presence of the G
allele, whether in a heterozygous or homozygous state, is
associated with a higher incidence of GDM. Out of 44
cases, 29 had at least one G allele compared to just 19 out
of 44 control participants. Moreover, it has been shown
that AHSG is a regulator of body mass as supported by a
linear relationship between the G allele and BMI. Contrary
to this an earlier study established that the G allele was
more common in lean men.8
Our study is limited in the fact that we could not perform
sequencing of the PCR products and we were unable to
recruit more subjects. Yet, this study adds a weak positive
link of AHSG and GDM in the existing pool of researches.

Conclusion
Fetuin-A levels were found to be increased in those with
GDM. We found that parameters of IR such as increased
responses to OGTT were increased in individuals with G
allele of AHSG rs4918 suggesting a link with IR.
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